Advanced search
Start date
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Oral administration of Saccharomyces cerevisiae UFMG A-905 prevents allergic asthma in mice

Full text
Fonseca, Vanessa M. B. ; Milani, Thamires M. S. ; Prado, Rafael ; Bonato, Vania L. D. ; Ramos, Simone G. ; Martins, Flaviano S. ; Vianna, Elcio O. ; Borges, Marcos de C.
Total Authors: 8
Document type: Journal article
Source: Respirology; v. 22, n. 5, p. 905-912, JUL 2017.
Web of Science Citations: 8

Background and objectiveThe prevalence of asthma has increased in communities that adopt a Western lifestyle and become more urbanized. Probiotics may be effective in the prevention of allergic diseases, such as asthma. The aim of the current study was to examine the effects of Saccharomyces cerevisiaeUFMG A-905 in an allergic model of asthma. MethodsBalb/c mice were sensitized twice with ovalbumin (OVA) intraperitoneally, 1week apart and challenged with OVA intranasally for 3days. Mice were daily treated with S. cerevisiaeUFMG A-905 via gavaging needle 10days before OVA sensitization and during challenges. After challenge, in vivo lung function was measured, and bronchoalveolar lavage (BAL) and lung inflammation were assessed. ResultsOral treatment with S. cerevisiaeUFMG A-905 significantly decreased airway hyperresponsiveness, total cell number and the influx of eosinophils to the airway, inflammatory cell in the lung, mucus expression in epithelial cells and the levels of IL-4, IL-5 and IL-13. Additionally, S. cerevisiaeUFMG A-905 restored the levels of IL-10 and interferon (IFN)-gamma, and increased the levels of IL-17A. ConclusionOral administration of S. cerevisiaeUFMG A-905 prevented the development of major asthma-like characteristics in a mouse model. (AU)

FAPESP's process: 10/20600-4 - Study of asthma prevention and treatment with the administration of viable and heat-killed Saccharomyces cerevisiae in a murine model of allergic asthma
Grantee:Marcos de Carvalho Borges
Support type: Research Grants - Young Investigators Grants